• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ALXO

ALXO

ALX Oncology Holdings Inc.

NASDAQHealthcareBiotechnologyUS

USD1.78

-0.02 (-1.11%)

Rating:C+

Company Profile

CEO

Jason W. Lettmann

IPO Date

2020-07-17

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.76

Prev. Close

$1.80

Day Low

$1.69

Day High

$1.82

52W Low

$0.40

52W High

$2.66

Market Cap

$0.24B

Volume

0.86M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Insider Trades
FiledInsiderRoleTypeA/DSharesPrice
17 Apr 2026Knight Jeff E.Chief Dev & Operating OfficerA-AwardAcquired800,000$1.68
17 Apr 2026Klencke BarbaraChief Medical OfficerA-AwardAcquired
100,000
$1.68
17 Apr 2026Knight Jeff E.—Disposed0$0.00
23 Mar 2026Lettmann Jasondirector, officer: CHIEF EXECUTIVE OFFICERS-SaleDisposed12,311$2.17
23 Mar 2026Pinto ShellySVP, FINANCE AND CAOS-SaleDisposed903$2.17
5 Mar 2026Klencke BarbaraChief Medical OfficerA-AwardAcquired700,000$2.07
5 Mar 2026Klencke BarbaraChief Medical OfficerDisposed0$0.00
5 Mar 2026Klencke BarbaraChief Medical OfficerDisposed40,400$1.65
5 Mar 2026Klencke BarbaraChief Medical OfficerDisposed300,000$1.05
5 Mar 2026Klencke BarbaraChief Medical OfficerDisposed100,000$1.48